Copertina

Metformin Intervention Trial Targeting Post-Exertional Malaise (PEM) in ME/CFS

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	Eshuis, Erik
Natura:	Recurso digital
Lingua:	inglese
Pubblicazione:	Zenodo 2025
Soggetti:	Myalgic Encephalomyelitis ME/CFS Post-Exertional Malaise Metabolic dysregulation AMPK activation Mitochondrial dysfunction Lactate metabolism Oxygen extraction Autonomic dysfunction Metformin Energy Metabolism Energy Metabolism/immunology Pyruvate dehydrogenase (PDH)
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Adaptive Overcommitment in Ebola Virus Disease
di: Dominik, Matthew
Pubblicazione: (2026)

Preventing ovarian aging: from redox-targeted strategies to extracellular vesicle-based therapies
di: Camerano Spelta Rapini, Chiara, et al.
Pubblicazione: (2026)

Metabolic pathway modulation and oxidative imbalance triggered by decamethylcyclopentasiloxane (D5) in zebrafish embryo.
di: Andrade, Ítalo B L de, et al.
Pubblicazione: (2026)

Sexual dysfunction in females with depression: a crosssectional study
di: Krishnankutty Sreelakshmy
Pubblicazione: (2017)

Progressive posterior cortical dysfunction
di: Fábio Henrique de Gobbi Porto
Pubblicazione: (2010)

Síndroma de fadiga crónica (CFS): aprender, educar e agir
di: Clara Oliveira
Pubblicazione: (2004)

Magnesium as a Bioenergetic Checkpoint Linking Mitochondrial Function, Metabolic Disease, and Aging.
di: Huang, Chien-Wei, et al.
Pubblicazione: (2026)

Swimming respirometry provides insights into the physiological energetics of juvenile Atlantic bluefin tuna Thunnus thynnus.
di: McKenzie, David J, et al.
Pubblicazione: (2026)

Change in Activities of Enzymes of Energy and Carbohydrate Metabolism in Pink Salmon Oncorhynchus gorbuscha (Walb.) Smolts with Change in Environmental Salinity.
di: Shulgina, N S, et al.
Pubblicazione: (2024)

AI.LC-Analyzer – Technical Documentation V9.46. - Phase 1: A mechanistic system architecture for trajectory-based analysis of chronic disease dynamics
di: Fuerste, Dietmar
Pubblicazione: (2026)

Chronic intermittent hypoxia modulates energy metabolic pathways and improves hypoxia tolerance capacity in golden pompano, Trachinotus blochii.
di: Fang, Geng Hui, et al.
Pubblicazione: (2025)

MEG resting-state differences as a marker of clinical subtype in schizophrenia
di: M Manzano, José, et al.
Pubblicazione: (2017)

Ketosis, Metabolic Flexibility, and the Nutritional Science of Balance
di: Rahman, Sharaf Samiur
Pubblicazione: (2025)

Models and Analysis of Vocal Emissions for Biomedical Applications
Pubblicazione: (2022)

ERECTILE DYSFUNCTION IN MALE GERIATRIC POPULATION WITH ARTERIAL HYPERTENSION IN TEGUCIGALPA HONDURAS
di: María José Folgar Contreras
Pubblicazione: (2018)

From Ethnobotany to Immunometabolism: Network Pharmacology Analysis of Nigerian Medicinal Plants as Modulators of Immune-Metabolic Pathways in Obesity and Type 2 Diabetes
di: Jesutofunmi Adeyemi Samson
Pubblicazione: (2026)

Marine iguanas have lower metabolic rates during El Niño.
di: Dubiner, Shahar, et al.
Pubblicazione: (2025)

Water-borne cortisol is correlated with acclimatization temperature but not metabolic rate in a teleost fish.
di: Sniecinski, Elisa, et al.
Pubblicazione: (2026)

Metformin continuation post‐metabolic bariatric surgery and relapse of diabetes
di: Dror Dicker, et al.
Pubblicazione: (2024)

Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
di: MG Sousa
Pubblicazione: (2014)

Rasmussen encephalitis: an older adult presentation?
di: Ricardo Pires Alvim
Pubblicazione: (2020)

METRIC PROPERTIES OF A PORTUGUESE VERSION OF THE ABRIDGED, 5-ITEM VERSION OF THE INTERNATIONAL INDEX OF ERECTILE FUNCTION (IIEF-5)
di: J.L. Pais Ribeiro
Pubblicazione: (2007)

Cognitive dysfunction in spinocerebellar ataxias
di: Helio Alfonso Ghizoni Teive
Pubblicazione: (2009)

Metformin beyond type 2 diabetes: Emerging and potential new indications
di: John R. Petrie
Pubblicazione: (2024)

Metformin use associated with lower rate of hospitalization for influenza in individuals with diabetes
di: Elizabeth Greene, et al.
Pubblicazione: (2024)

Metformin lowers risk of hearing loss and mortality in type 2 diabetes
di: Chun‐Chih Huang, et al.
Pubblicazione: (2024)

Basic concepts of metabolic flux analysis
di: Claudia Patricia Sánchez Henao
Pubblicazione: (2021)

Does oral sildenafil improve secondary pulmonary hypertension in critically ill patients with right ventricular dysfunction?
di: Tripdatabase
Pubblicazione: (2026)

Metformin use in women with polycystic ovary syndrome ( PCOS ): Opportunities, benefits, and clinical challenges
di: Saeede Saadati, et al.
Pubblicazione: (2025)

Metformin slows intestinal glucose absorption in type 2 diabetes, irrespective of the timing of its administration
di: Malcolm J. Borg, et al.
Pubblicazione: (2025)

Impact of Metformin Therapy on Vitamin B12 Levels in Patients With Type 2 Diabetes Mellitus
di: Sahar H. Mahmoud, et al.
Pubblicazione: (2025)

Reply to “A comment on ‘Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was’”
di: Brian Eric Rittenhouse, et al.
Pubblicazione: (2025)

Evaluating the Impact of Putative Metformin Targets on Cancer Outcomes: A Drug‐Target Mendelian Randomization Study
di: Xingyu Shen, et al.
Pubblicazione: (2026)

The Influence of OCT3 and MATE2 Genetic Polymorphisms in Poor Response to Metformin in Type 2 Diabetes Mellitus
di: Alaa Abd Al‐Hussain Naem, et al.
Pubblicazione: (2024)

Metformin use in prediabetes: A review of evidence and a focus on metabolic features among peri‐menopausal women
di: Beth Shi Yu Lim, et al.
Pubblicazione: (2025)

Association of Metformin use with risk of dementia in patients with type 2 diabetes: A systematic review and meta‐analysis
di: Chunbian Tang, et al.
Pubblicazione: (2025)

The Impact of Metformin on Vitamin B12 Levels in Children and Adolescents: A Systematic Review and Single‐Arm Meta‐Analysis
di: Einas Abdullah Tahir, et al.
Pubblicazione: (2026)

The Efficacy of Imeglimin and Metformin on Insulin Sensitivity and Secretion Using Oral Minimal Model: Sub‐Analysis of an Exploratory Randomised Controlled Trial
di: Ryota Usui, et al.
Pubblicazione: (2026)

Metformin monotherapy versus predominantly older non‐metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes management
di: Mingyang Sun, et al.
Pubblicazione: (2024)

Respiration rates and inferred mass-specific field metabolic rates decline with body size among five sympatric cetaceans.
di: Glarou, Maria, et al.
Pubblicazione: (2025)